Chen Jing, Muntner Paul, Hamm L Lee, Jones Daniel W, Batuman Vecihi, Fonseca Vivian, Whelton Paul K, He Jiang
Tulane University Schools of Medicine and Public Health and Tropical Medicine, New Orleans, Louisiana 70112, USA.
Ann Intern Med. 2004 Feb 3;140(3):167-74. doi: 10.7326/0003-4819-140-3-200402030-00007.
The metabolic syndrome is a common risk factor for cardiovascular disease.
To examine the association between the metabolic syndrome and risk for chronic kidney disease and microalbuminuria.
Cross-sectional study.
The Third National Health and Nutrition Examination Survey.
Participants 20 years of age or older were studied in the chronic kidney disease (n = 6217) and microalbuminuria (n = 6125) analyses.
The metabolic syndrome was defined as the presence of 3 or more of the following risk factors: elevated blood pressure, low high-density lipoprotein cholesterol level, high triglyceride level, elevated glucose level, and abdominal obesity. Chronic kidney disease was defined as a glomerular filtration rate less than 60 mL/min per 1.73 m2, and microalbuminuria was defined as a urinary albumin-creatinine ratio of 30 to 300 mg/g.
The multivariate-adjusted odds ratios of chronic kidney disease and microalbuminuria in participants with the metabolic syndrome compared with participants without the metabolic syndrome were 2.60 (95% CI, 1.68 to 4.03) and 1.89 (CI, 1.34 to 2.67), respectively. Compared with participants with 0 or 1 component of the metabolic syndrome, participants with 2, 3, 4, and 5 components of chronic kidney disease had multivariate-adjusted odds ratios of 2.21 (CI, 1.16 to 4.24), 3.38 (CI, 1.48 to 7.69), 4.23 (CI, 2.06 to 8.63), and 5.85 (CI, 3.11 to 11.0), respectively. The corresponding multivariate-adjusted odds ratios of microalbuminuria for participants with 3, 4, and 5 components were 1.62 (CI, 1.10 to 2.38), 2.45 (CI, 1.55 to 3.85), and 3.19 (CI, 1.96 to 5.19), respectively.
These findings suggest that the metabolic syndrome might be an important factor in the cause of chronic kidney disease.
代谢综合征是心血管疾病的常见危险因素。
研究代谢综合征与慢性肾脏病及微量白蛋白尿风险之间的关联。
横断面研究。
第三次全国健康与营养检查调查。
对20岁及以上的参与者进行慢性肾脏病(n = 6217)和微量白蛋白尿(n = 6125)分析。
代谢综合征定义为存在以下3种或更多危险因素:血压升高、高密度脂蛋白胆固醇水平降低、甘油三酯水平升高、血糖水平升高和腹型肥胖。慢性肾脏病定义为肾小球滤过率低于60 ml/min/1.73 m²,微量白蛋白尿定义为尿白蛋白肌酐比值为30至300 mg/g。
与无代谢综合征的参与者相比,有代谢综合征的参与者发生慢性肾脏病和微量白蛋白尿的多变量调整比值比分别为2.60(95%CI,1.68至4.03)和1.89(CI,1.34至2.67)。与具有0或1项代谢综合征组分的参与者相比,具有2、3、4和5项慢性肾脏病组分的参与者的多变量调整比值比分别为2.21(CI,1.16至4.24)、3.38(CI,1.48至7.69)、4.23(CI,2.06至8.63)和5.85(CI,3.11至11.0)。具有3、4和5项组分的参与者微量白蛋白尿的相应多变量调整比值比分别为1.62(CI,1.10至2.38)、2.45(CI,1.55至3.85)和3.19(CI,1.96至5.19)。
这些发现表明代谢综合征可能是慢性肾脏病病因中的一个重要因素。